Brand profile · Biotechnology Research

Aegros

Macquarie Park, NSW-based Aegros operates in Biotechnology Research. Ownership is privately held; it publishes at aegros.com.au. It holds one address on record, all in Australia. The record counts 67 people. Tagged therapeutic plasma products and Building of therapeutic plasma facilities. One Australian registration (ABN) is a confirmed match. It is listed alongside seven similar brands, mostly in Biotechnology Research.

Profile live Privately Held Founded 2017 1 entity ABN 1 office country
Registry verified · ABR

Key facts

Counted staff
67
self-reported 51–200 band
Founded
2017
9 years
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
None on record
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity
  • AEGROS LTD

    ABN92618589101

    NSWHigh confidenceMatched on exact nameABR

Legal entities

Aegros: 1 registry entityAegros is linked to 1 registry entity: AEGROS LTD (ABN 92618589101, candidate).AegrosAEGROS LTDABN 92618589101Candidate · High confidence
Show as table · Aegros: 1 registry entity
Aegros: 1 registry entity
AEGROS LTDABN 92618589101
Confirmed matches0 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

At Aegros we believe access to life saving therapeutic plasma drugs is a human right and not a privilege.

Our mission is to put the patient first through innovation and we do this thanks to our Australian invented Haemafrac®, Aegros' unique electroseparation process.

Our TGA GMP-approved plasma fractionation plant in Macquarie Park, Sydney, manufactures a hyperimmune immunoglobulin product against Covid-19, made from convalescent plasma.

Aegros is currently undertaking the final preparations for the submission of a dossier for the registration of this hyperimmune against Covid-19 on the Australian Register of Therapeutic Goods (ARTG)

Simultaneously, Aegros is finishing the upgrade of its existing hyperimmune facility at Macquarie Park NSW to be able to process 100,000l of plasma per year.

Specialties

All 1 specialty
  • Therapeutic plasma products and Building of therapeutic plasma facilities

Locations

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary AU. Codes: AU.1 countryprimary AUAU
Show as table · Offices in 1 country
Offices in 1 country
Countries1
Primary countryAU

All codes: AU

Addresses

  • AU5 Eden Park Drive; Macquarie Park, NSW 2113Primary

Grid intelligence Members

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

4 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under Aegros?

One New South Wales entity on the ABR. AEGROS LTD (ABN 92 618 589 101), high confidence.

How many people work at Aegros?

The record holds 67 counted staff profiles at January 2026, inside the self-reported 51–200 band.

Where does Aegros have offices?

One address on record, Australia only. Primary: 5 Eden Park Drive, Macquarie Park, NSW 2113.

Has Aegros raised funding?

None linked to this brand.

What does Aegros list as its specialties?

One tag on the brand's own list, among them Therapeutic plasma products and Building of therapeutic plasma facilities.

Which companies are listed alongside Aegros?

28 profiles list Aegros as a peer — 96th percentile in Biotechnology Research. It lists ten peers of its own. Inventia Life Science and Regeneus Ltd list it back.

What is Aegros's website?